DANE DICKSON, MD
CEO and Founder
Dr. Dickson is a medical oncologist with deep experience in clinical trial reporting, molecular medicine, and data collection.
MICK SIMON
President and Chief Technology Officer
Mick is President and acting Chief Technology Officer, guiding the operational and technology development of the Taproot Platform.
MITCH GALLOWAY
Chief Strategy Officer
Mr. Galloway has spent over 40 years in the healthcare sector as a hospital operator, consultant, and a serial entrepreneur.
GUY FORDHAM
Senior Vice President of Finance
Guy is a seasoned leader in all aspects of healthcare information technology finance.
LORI MILES
Director of Clinical Operations
Lori is an experienced program manager with over 11 years of experience in clinical trial work.
Renee Ubico
Clinical Site Manager
Renee is an expert in building relationships between medical providers, patients, and research teams to improve health outcomes.
RAZELLE KURZROCK, M.D.
Principal Investigator and Scientific Advisor
Chief, Division of Hematology & Oncology | Director, Center for Personalized Cancer Therapy & Clinical Trials Office | Senior Deputy Director, Clinical Science | Moores Cancer Center, University of California at San Diego.
RAYMOND BERGAN, M.D.
Principal Investigator and Scientific Advisor
Chief, Division of Hematology & Medical Oncology, Associate Director, Knight Cancer Institute.
JENNIFER JOHNSON, M.D., PHD
Principal Investigator and Scientific Advisor
Assistant Professor, Department of Medical Oncology, Thomas Jefferson
VIVEK SUBBIAH, M.D.
Principal Investigator and Scientific Advisor
Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.